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ABSTRACT
MicroRNAs (miRNAs) regulate gene expression
at the posttranscriptional level and are therefore
important cellular components. As is true for
protein-coding genes, the transcription of miRNAs
is regulated by transcription factors (TFs), an impor-
tant class of gene regulators that act at the
transcriptional level. The correct regulation of
miRNAs by TFs is critical, and increasing evidence
indicates that aberrant regulation of miRNAs by
TFs can cause phenotypic variations and diseases.
Therefore, a TF–miRNA regulation database would
be helpful for understanding the mechanisms by
which TFs regulate miRNAs and understanding
their contribution to diseases. In this study, we
manually surveyed approximately 5000 reports in
the literature and identified 243 TF–miRNA regula-
tory relationships, which were supported experi-
mentally from 86 publications. We used these data
to build a TF–miRNA regulatory database (TransmiR,
http://cmbi.bjmu.edu.cn/transmir), which contains
82 TFs and 100 miRNAs with 243 regulatory pairs
between TFs and miRNAs. In addition, we included
references to the published literature (PubMed ID)
information about the organism in which the rela-
tionship was found, whether the TFs and miRNAs
are involved with tumors, miRNA function annota-
tion and miRNA-associated disease annotation.
TransmiR provides a user-friendly interface by
which interested parties can easily retrieve TF–
miRNA regulatory pairs by searching for either a
miRNA or a TF.
INTRODUCTION
MicroRNAs (miRNAs) are endogenous small ( 22nt)
noncoding regulatory RNAs that typically function as
negative regulators of mRNA expression at the
posttranscriptional level. They act by binding to the 30-
untranslated regions (30-UTRs) of target mRNAs
through base pairing to complementary sequences. This
binding results in cleavage or translation inhibition
of the target mRNAs (1–3). miRNAs play critical roles
in many essential biological processes, such as prolifera-
tion (4,5), metabolism (6,7), diﬀerentiation (8), develop-
ment (9,10), apoptosis (7,11,12) and cellular signaling
(13). Because of their biological importance, the
dysfunction of speciﬁc miRNAs is associated with a
variety of diseases, such as cancer and cardiovascular
diseases (8,14,15).
No genes are completely independent but rather they
interact with other genes. In case of miRNAs, they
usually aﬀect downstream molecules by regulating the
expression of target genes. Estimates suggest that  1–4%
of genes in the human genome encode miRNAs and that a
single miRNA can regulate as many as 200 mRNAs (8).
Furthermore, the expression of miRNAs can be activated
or repressed by transcription factors (TFs), which there-
fore can serve as upstream regulators of miRNA. In recent
years, many researchers have attempted to understand how
miRNAs act to regulate target genes and what their roles
are in various diseases. However, the study of miRNA reg-
ulation by TFs (TF–miRNA regulation) has been rela-
tively limited. We reported previously that miRNAs and
TFs may cooperate to tune gene expression (16). In
addition, miRNAs and TFs can form feedback or feed-
forward loops, which play critical roles in various biolog-
ical processes. For example, Yamakuchi and Lowenstein
(17) reported a feedback loop in which p53 induces expres-
sion of miR-34a, which in turn suppresses the expression
of SIRT1 and thus increases p53 activity. Increasing
evidence suggests that aberrant regulation of miRNAs by
TFs can cause diseases (18). Therefore, TF–miRNA regu-
lation is one of the most important aspects of the study of
both miRNAs and TFs and is attracting the interest of
increasing numbers of researchers. For this reason, a
high-quality TF–miRNA regulation database will be of
great help in the study of both the regulation of miRNAs
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However, such a database has not been available. To
establish a database of TF–miRNA regulation, we
manually curated the TF–miRNA regulatory relations
that have been reported in literature and created a
database that we named ‘TransmiR’. Finally, we gave a
simple example for the application of TransmiR by
analyzing the association between the conservation and
degree of miRNAs. Although the ‘TransmiR’ database
represents only the ﬁrst step in this project, it should
become a valuable ongoing resource for the study of TF–
miRNA regulation.
DATA SOURCES AND IMPLEMENTATION
We ﬁrst searched PubMed by the keywords ‘microRNA’
or ‘miRNA’ and then downloaded the search results that
had been recorded before April 2009 from the National
Center for Biotechnology Information (NCBI). From this
search, we obtained  5000 papers that contained the
words ‘microRNA’ or ‘miRNA’. Next, we curated the
data manually and retrieved TF–miRNA regulatory
pairs that related to the regulation of miRNAs by TFs.
Diﬀerent researchers double-checked all TF–miRNA
pairs. We also noted whether a particular TF activated
or repressed the expression of its miRNA partner. The
database includes PubMed IDs and hyperlinks to the
original PubMed articles as well as a hyperlink to NCBI
(http://www.ncbi.nlm.nih.gov/) for each TF. This will
enable researchers to easily access annotations such as
functions, cellular components and biological processes
in which the TF is involved, as well as their related
disease. We annotated each miRNA according to
whether it is associated with tumor and other diseases
using the human microRNA disease database (HMDD,
http://cmbi.bjmu.edu.cn/hmdd) (15). We also annotated
the functions of each miRNA using the miRNA
function database UCbase (19).
All data were organized in the ‘TransmiR’ database
using SQLite, a lightweight database management
system. The website is presented using Django, a Python
web framework and is available at http://cmbi.bjmu.edu.
cn/transmir. TransmiR provides several search options,
name of the TF, miRNA ID or both.
A CASE USING TF-miRNA DATA
TransmiR represents a valuable resource for the study of
TF–miRNA regulation and can be used to analyze various
processes, such as the evolution of the interactions, expres-
sion patterns and associated diseases of miRNAs. As an
example, in this study we assembled a human TF–miRNA
regulatory network (Figure 1) and performed a prelimi-
nary analysis of it. As shown in Figure 1, the largest
Figure 1. The human TF–miRNA regulatory network. Green circles represent TFs and red circles represent miRNAs.
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original network nodes, which suggests that many TFs/
miRNAs interact with other miRNAs/TFs. A single
miRNA could be regulated by diﬀerent TFs and one TF
could regulate multiple miRNAs. These ﬁndings indicate
that the regulatory relationships between TFs and
miRNAs are complex. Both the TF and the miRNA
nodes had skewed degree (the number of connections to
a node) distribution. These skewed distributions suggest
that most TFs regulate just a few miRNAs and, in
addition, that most miRNAs are regulated by a small
number of TFs. However, it also means that some hub
TFs and miRNAs showed a very high number of
connections, which suggests that they may play essential
roles in TF–miRNA regulation. For example, MYC
regulated 26 miRNAs, and miR-20a was regulated by
seven TFs. Degree is a measure of node centrality in a
network. Those nodes that interact with a greater
number of nodes than others are normally more important
in cellular functioning and could represent factors that
would be more highly conserved in evolution (20).
Previously, we revealed a correlation between conserva-
tion and the degree of a protein (21). However, no
previous research has shown whether this pattern exists
in TF–miRNA network. In order to address this issue,
we investigated the correlation between conservation and
degree for the miRNAs. We evaluated miRNA conserva-
tion using data on miRNA families and the method pre-
sented by Zhang et al. (22). Human miRNAs were
classiﬁed into ﬁve groups according to their level of con-
servation: miRNAs that were present only in humans (G5),
conserved in primates (G4), conserved in mammals
(G3), conserved in vertebrates (G2) and those that were
conserved in other more distant species (G1, the most
conserved group). We classiﬁed the miRNAs in the
network into two groups according to their degree: the
high-degree group (degree  3) and the low-degree group
(degree <3). We evaluated the level of conservation for the
miRNAs in these two groups. As expected, we found that
the miRNAs in the high-degree groups were more
conserved (i.e. a greater number were in G1, P=0.02,
Fisher’s exact test) than those in the low-degree group
(Table 1). This suggests that miRNAs that are regulated
by a large number of TFs tend to be highly conserved
during evolution.
FUTURE EXTENSIONS
The TransmiR database represents the ﬁrst step in this
project and further extensions should be developed.
As we described above, feedback/feed-forward loops
represent two critical local interactions between TFs and
miRNAs. Therefore, we plan to curate feedback/feed-
forward loops between TFs and miRNAs and integrate
them into TransmiR. Furthermore, we will also incorpo-
rate miRNA target data that is supported experimentally.
In addition, we will classify both TFs and miRNAs into
more detailed clusters according to their associations
with various diseases, such as cancer or cardiovascular
diseases. Finally, we will include additional annotations,
such as expression patterns (23), and conservation during
evolution will be included in future updates. We plan to
continuously update TransmiR.
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